alendronate has been researched along with hydrochlorothiazide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Borgström, F; Jönsson, B; Kanis, JA; Ström, O; Zethraeus, N | 1 |
| Arias-Santiago, S; Arrabal-Martin, M; Arrabal-Polo, MA; de Haro-Muñoz, T; Gonzalez-Torres, S; Lopez-Ruiz, A; Orgaz-Molina, J; Zuluaga-Gomez, A | 1 |
| Ábalos-Medina, GM; del Mar Almagro Ratia, M; Fernández Rodríguez, I; Fuentes Ellauri, MA | 1 |
| Abad-Menor, F; Arrabal-Martín, M; Arrabal-Polo, MÁ; Cano-García, MD; Cózar-Olmo, JM; De Haro-Muñoz, T; González-Torres, S | 1 |
1 review(s) available for alendronate and hydrochlorothiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for alendronate and hydrochlorothiazide
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.
Topics: Aged; Aged, 80 and over; Alendronate; Antihypertensive Agents; Bone Density Conservation Agents; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Middle Aged; Models, Econometric; Osteoporosis, Postmenopausal; Quality-Adjusted Life Years; Simvastatin; Sweden | 2008 |
Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Female; Humans; Hydrochlorothiazide; Hypercalciuria; Kidney Calculi; Male; Middle Aged; Nephrolithiasis; Osteoporosis; Prospective Studies; Recurrence; Sodium Chloride Symporter Inhibitors | 2013 |
[Mineral and bone disorder associated with Cacchi-Ricci disease].
Topics: Adult; Alendronate; Bone Density Conservation Agents; Bone Remodeling; Calcifediol; Calcium; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypercalciuria; Male; Medullary Sponge Kidney; Osteoporosis | 2014 |
Urine Calcium and Bone Mineral Density in Calcium Stone-Forming Patients Treated with Alendronate and Hydrochlorothiazide.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Diuretics; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Kidney Calculi; Male; Middle Aged; Prospective Studies; Recurrence; Time Factors | 2016 |